These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 11807629

  • 1. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.
    Sevilla J, Rodríguez A, Hernández-Maraver D, de Bustos G, Aguado J, Ojeda E, Arrieta R, Hernández-Navarro F.
    Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629
    [Abstract] [Full Text] [Related]

  • 2. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf, Amigo Mf, Hernández JM, Sanz G, Núñez R, Carreras E, Alegre A, Cuesta B, Mataix R.
    Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
    [Abstract] [Full Text] [Related]

  • 3. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L, Chiusolo P, Garzia MG, Zini G, Sorà F, Piccirillo N, Piccioni P, Zollino M, Leone G, Sica S.
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [Abstract] [Full Text] [Related]

  • 4. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B.
    J Clin Oncol; 2006 Aug 01; 24(22):3604-10. PubMed ID: 16877727
    [Abstract] [Full Text] [Related]

  • 5. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
    Sobecks RM, Le Beau MM, Anastasi J, Williams SF.
    Bone Marrow Transplant; 1999 Jun 01; 23(11):1161-5. PubMed ID: 10382956
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A, de la Rubia J, Martín G, Martínez J, Sanz G, Jarque I, Sempere A, Soler MA, Marty ML, Sanz MA.
    Bone Marrow Transplant; 2002 May 01; 29(10):825-32. PubMed ID: 12058232
    [Abstract] [Full Text] [Related]

  • 8. Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies.
    Park S, Brice P, Noguerra ME, Simon D, Rousselot P, Kerneis Y, Morel P, Marolleau JP, Gisselbrecht C.
    Bone Marrow Transplant; 2000 Aug 01; 26(3):321-6. PubMed ID: 10967573
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R, Van Heijzen K, Palmer A, Komiya A, Slovak ML, Chang KL, Fung H, Krishnan A, Molina A, Nademanee A, O'Donnell M, Popplewell L, Rodriguez R, Forman SJ, Bhatia S.
    J Clin Oncol; 2005 Sep 20; 23(27):6699-711. PubMed ID: 16170178
    [Abstract] [Full Text] [Related]

  • 10. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prósper F, Solano C, García Clavel B, Marugán I, Lluch A, García-Conde J.
    Bone Marrow Transplant; 2000 Jun 20; 25(11):1203-8. PubMed ID: 10849534
    [Abstract] [Full Text] [Related]

  • 11. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 Sep 15; 21(18):3440-6. PubMed ID: 12668650
    [Abstract] [Full Text] [Related]

  • 12. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S, Nademanee A, Qian D, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L, Forman S.
    Transfusion; 2007 Dec 15; 47(12):2207-16. PubMed ID: 17714420
    [Abstract] [Full Text] [Related]

  • 13. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
    Hake CR, Graubert TA, Fenske TS.
    Bone Marrow Transplant; 2007 Jan 15; 39(2):59-70. PubMed ID: 17143301
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML, del Cañizo MC, Rios A, Garcia MA, Caballero MD, Martin A, Bermejo N, Vilches P, San Miguel JF.
    Bone Marrow Transplant; 1999 May 15; 23(10):997-1002. PubMed ID: 10373064
    [Abstract] [Full Text] [Related]

  • 15. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F, Cavenaghi L, de Melo CM.
    Transfus Apher Sci; 2009 Apr 15; 40(2):91-5. PubMed ID: 19233728
    [Abstract] [Full Text] [Related]

  • 16. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.
    J Clin Oncol; 2005 Nov 01; 23(31):7994-8002. PubMed ID: 16204014
    [Abstract] [Full Text] [Related]

  • 17. Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Roberts MM, Dyson PG, Willson K, Juttner CA, To LB.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):41-5. PubMed ID: 8831994
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.
    Exp Hematol; 2003 Jan 01; 31(1):89-97. PubMed ID: 12543111
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.